These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studies. Wang LW; Fahim MA; Hayen A; Mitchell RL; Lord SW; Baines LA; Craig JC; Webster AC Am J Kidney Dis; 2011 Mar; 57(3):476-87. PubMed ID: 21257239 [TBL] [Abstract][Full Text] [Related]
4. Is standardized cardiac assessment of asymptomatic high-risk renal transplant candidates beneficial? Aalten J; Peeters SA; van der Vlugt MJ; Hoitsma AJ Nephrol Dial Transplant; 2011 Sep; 26(9):3006-12. PubMed ID: 21321004 [TBL] [Abstract][Full Text] [Related]
5. Pre-transplant cardiac testing for kidney-pancreas transplant candidates and association with cardiac outcomes. Lin K; Stewart D; Cooper S; Davis CL Clin Transplant; 2001 Aug; 15(4):269-75. PubMed ID: 11683822 [TBL] [Abstract][Full Text] [Related]
6. Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography, and dobutamine Tc-99m sestamibi tomoscintigraphy. Van Damme H; Piérard L; Gillain D; Benoit T; Rigo P; Limet R Cardiovasc Surg; 1997 Feb; 5(1):54-64. PubMed ID: 9158124 [TBL] [Abstract][Full Text] [Related]
7. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation. Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P; Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361 [TBL] [Abstract][Full Text] [Related]
8. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Herzog CA; Marwick TH; Pheley AM; White CW; Rao VK; Dick CD Am J Kidney Dis; 1999 Jun; 33(6):1080-90. PubMed ID: 10352196 [TBL] [Abstract][Full Text] [Related]
9. Screening for cardiovascular disease before kidney transplantation. Palepu S; Prasad GV World J Transplant; 2015 Dec; 5(4):276-86. PubMed ID: 26722655 [TBL] [Abstract][Full Text] [Related]
10. Pre-Operative Cardiovascular Testing and Post-Renal Transplant Clinical Outcomes. Yang M; Miller PJ; Case BC; Gilbert AJ; Widell JK; Rogers T; Satler LF; Waksman R; Ben-Dor I Cardiovasc Revasc Med; 2019 Jul; 20(7):588-593. PubMed ID: 31097384 [TBL] [Abstract][Full Text] [Related]
11. Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. Marwick TH; Lauer MS; Lobo A; Nally J; Braun W J Intern Med; 1998 Aug; 244(2):155-61. PubMed ID: 10095802 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal complications in patients receiving a solid-organ transplant. Diaz G; O'Connor M Curr Opin Crit Care; 2011 Aug; 17(4):382-9. PubMed ID: 21677579 [TBL] [Abstract][Full Text] [Related]
13. [Coronary ischemia after kidney transplantation in patients over 60 years of age]. Cristol JP; Mourad G; Rebillard X; Guiter J; Mion C Presse Med; 1991 Nov; 20(40):2019-21. PubMed ID: 1837116 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Mistry BM; Bastani B; Solomon H; Hoff J; Aridge DL; Lindsey LM; Schmid S; Chaitman BR; Garvin PJ Clin Transplant; 1998 Apr; 12(2):130-5. PubMed ID: 9575401 [TBL] [Abstract][Full Text] [Related]
16. Pretransplant cardiac investigations in the Irish renal transplant population--the effectiveness of our current screening techniques in predicting cardiac events. Ali M; Giblin L; Farhad K; O'Kelly P; Hickey D; Little D; Donohoe J; Walshe JJ; Conlon PJ Ren Fail; 2004 Jul; 26(4):375-80. PubMed ID: 15462104 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Sharples L; Hughes V; Crean A; Dyer M; Buxton M; Goldsmith K; Stone D Health Technol Assess; 2007 Dec; 11(49):iii-iv, ix-115. PubMed ID: 18021576 [TBL] [Abstract][Full Text] [Related]
18. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT). Boden WE; van Gilst WH; Scheldewaert RG; Starkey IR; Carlier MF; Julian DG; Whitehead A; Bertrand ME; Col JJ; Pedersen OL; Lie KI; Santoni JP; Fox KM Lancet; 2000 May; 355(9217):1751-6. PubMed ID: 10832825 [TBL] [Abstract][Full Text] [Related]
19. Validation of a strategy to diagnose coronary artery disease and predict cardiac events in high-risk renal transplant candidates. De Lima JJ; Wolff Gowdak LH; de Paula FJ; Ianhez LE; Franchini Ramires JA; Krieger EM Coron Artery Dis; 2010 May; 21(3):164-7. PubMed ID: 20299981 [TBL] [Abstract][Full Text] [Related]